Previous study showed that overexpression of Gologh3 in 7 kinds of breast cancers promoted the proliferation with the downregulation of cyclin-dependent kinase (CDK) inhibitor p21Cip1 and upregulated the CDK regulator cyclin D1 [8]. This evidence concerns the gene CDKN1A and breast carcinoma.